Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades

Barbara K. Rimer net worth and biography

Barbara Rimer Biography and Net Worth

Director of Aflac

Dr. Rimer has been dean of the University of North Carolina Gillings School of Global Public Health since 2005, and alumni distinguished professor since 2003. Previously, she was director of the Division of Cancer Control and Population Sciences at the National Cancer Institute. She is a former director of Cancer Control Research and professor of community and family medicine at the Duke University School of Medicine. She was elected to the Institute of Medicine in 2008.

At the Gillings School of Public Health, Dr. Rimer works to improve public health, promote individual well-being, and eliminate health inequities across North Carolina and around the world. In 2012, Dr. Rimer was appointed Chairman of the President’s Cancer Panel and was reappointed twice since then. Her insight and leadership with respect to the public health sector are extremely relevant to the Company’s business and operations.

What is Barbara K. Rimer's net worth?: The estimated net worth of Barbara K. Rimer is at least $3.99 million as of May 2nd, 2023. Dr. Rimer owns 35,813 shares of Aflac stock worth more than $3,986,703 as of November 17th. This net worth estimate does not reflect any other assets that Dr. Rimer may own. Learn More about Barbara K. Rimer's net worth.
How do I contact Barbara K. Rimer?: The corporate mailing address for Dr. Rimer and other Aflac executives is 1932 WYNNTON ROAD, COLUMBUS GA, 31999. Aflac can also be reached via phone at (706) 323-3431 and via email at [email protected]. Learn More on Barbara K. Rimer's contact information.
Has Barbara K. Rimer been buying or selling shares of Aflac?: Barbara K. Rimer has not been actively trading shares of Aflac during the last ninety days. Most recently, Barbara K. Rimer sold 18,210 shares of the business's stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $68.18, for a transaction totalling $1,241,557.80. Following the completion of the sale, the director now directly owns 35,813 shares of the company's stock, valued at $2,441,730.34. Learn More on Barbara K. Rimer's trading history.
Who are Aflac's active insiders?: Aflac's insider roster includes Daniel Amos (President, Chairman & CEO), Koji Ariyoshi (VP), Steven Beaver (CFO), William Bowers (Director), Arthur Collins (Director), Frederick Crawford (COO), James Daniels (CFO), Toshihiko Fukuzawa (Director), June Howard (VP), Thomas Kenny (Director), Eric Kirsch (EVP), Georgette Kiser (Director), Masatoshi Koide (Director), Charles Lake, II (Director), Karole Lloyd (Director), Joseph Moskowitz (Director), Albert Riggieri (SVP), Barbara Rimer (Director), Audrey Tillman (EVP), and Teresa White (Insider). Learn More on Aflac's active insiders.
Are insiders buying or selling shares of Aflac?: During the last twelve months, insiders at the financial services provider sold shares 8 times. They sold a total of 74,585 shares worth more than $6,229,452.23. The most recent insider tranaction occured on August, 7th when Director Thomas J Kenny sold 2,000 shares worth more than $197,880.00. Insiders at Aflac own 0.9% of the company. Learn More about insider trades at Aflac.
Information on this page was last updated on 8/7/2024.

Barbara K. Rimer Insider Trading History at Aflac

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/2/2023	Sell	18,210	$68.18	$1,241,557.80	35,813
8/3/2022	Sell	11,026	$58.49	$644,910.74	33,413
12/11/2020	Sell	1,005	$44.62	$44,843.10	28,409
11/23/2020	Sell	932	$44.38	$41,362.16	29,468
7/26/2019	Sell	4,728	$53.74	$254,082.72	32,448
3/29/2017	Sell	1,412	$72.00	$101,664.00	12,852
12/14/2016	Sell	10,500	$70.14	$736,470.00	16,084
8/11/2016	Sell	186	$73.26	$13,626.36	12,074
8/1/2016	Sell	3,650	$71.74	$261,851.00	15,910

Barbara K. Rimer Buying and Selling Activity at Aflac

Aflac Company Overview

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Today's Range

Now: $111.32

$108.87

$111.91

50 Day Range

MA: $110.41

$104.51

$115.27

2 Week Range

Now: $111.32

$75.07

$115.50

Volume

2,895,295 shs

Average Volume

2,087,796 shs

Market Capitalization

$61.84 billion

P/E Ratio

16.77

Dividend Yield

1.80%

Beta

0.96

When it comes to NVDA… “acceleration cycles” are the key

From DTI | Ad

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!